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Background: Efficient production of SA in Escherichia coli has been achieved by modifying key genes of the central
carbon metabolism and SA pathway, resulting in overproducing strains grown in batch- or fed-batch-fermentor
cultures using a complex broth including glucose and YE. In this study, we performed a GTA to identify those genes
significantly upregulated in an engineered E. coli strain, PB12.SA22, in mid EXP (5 h), early STA (STA1, 9 h), and late
STA (STA2, 44 h) phases, grown in complex fermentation broth in batch-fermentor cultures.
Results: Growth of E. coli PB12.SA22 in complex fermentation broth for SA production resulted in an EXP growth
during the first 9 h of cultivation depending of supernatant available aromatic amino acids provided by YE because,
when tryptophan was totally consumed, cells entered into a second, low-growth phase (even in the presence of
glucose) until 26 h of cultivation. At this point, glucose was completely consumed but SA production continued
until the end of the fermentation (50 h) achieving the highest accumulation (7.63 g/L of SA). GTA between EXP/
STA1, EXP/STA2 and STA1/STA2 comparisons showed no significant differences in the regulation of genes encoding
enzymes of central carbon metabolism as in SA pathway, but those genes encoding enzymes involved in sugar,
amino acid, nucleotide/nucleoside, iron and sulfur transport; amino acid catabolism and biosynthesis; nucleotide/
nucleoside salvage; acid stress response and modification of IM and OM were upregulated between comparisons.
Conclusions: GTA during SA production in batch-fermentor cultures of strain PB12.SA22 grown in complex
fermentation broth during the EXP, STA1 and STA2 phases was studied. Significantly, upregulated genes during
the EXP and STA1 phases were associated with transport, amino acid catabolism, biosynthesis, and nucleotide/
nucleoside salvage. In STA2, upregulation of genes encoding transporters and enzymes involved in the synthesis
and catabolism of Arg suggests that this amino acid could have a key role in the fuelling of carbon toward SA
synthesis, whereas upregulation of genes involved in pH stress response, such as membrane modifications, suggests
a possible response to environmental conditions imposed on the cell at the end of the fermentation.
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The SA pathway is the common route leading to the
biosynthesis of aromatic compounds in bacteria and in
several eukaryotic organisms such as ascomycetes fungi,
Apicomplexa, and plants [1,2]. In Escherichia coli, the
first step in this pathway is the condensation of the
CCM intermediates PEP and E4P, into DAHP by the
DAHP synthase isoenzymes AroF, AroG, and AroH,
which are encoded by the aroF, aroG, and aroH genes,
respectively (Figure 1). The DHQ synthase, encoded by
aroB, converts DAHP into DHQ. Subsequently, DHQ
dehydratase, encoded by aroD, converts DHQ into DHS,
and this compound is then transformed to SA by shi-
kimate dehydrogenase, which is encoded by aroE. Shi-
kimate kinases I and II, encoded by aroL and aroK,
respectively, convert SA into S3P. Finally, S3P is con-
verted to EPSP by 3-phosphoshikimate-1-carboxyvinyl-
transferase, which is encoded by aroA. The last step in
the SA pathway is the synthesis of CHA by the CHA
synthase enzyme, which is encoded by aroC. CHA is the
common building block for the formation of aromatic
amino acids and compounds such as quinone, mena-
quinone and enterobactin [3-5].
SA is a commercially important compound because it
is considered to be an enantiomerically pure building
block that is used as the precursor for the synthesis of
numerous chemicals. Currently, SA has gained great im-
portance as the starting compound for the chemical syn-
thesis of OSP, the selective and potent inhibitor of the
neuraminidase enzyme located on the surface of the
influenza virus, known commercially as Tamiflu® andFigure 1 Central carbon metabolism and shikimic acid pathways in e
phosphorylation are performed by galactose permease (GalP) and glucokin
tktA, transketolase I; pykF, pyruvate kinase I; pykA, pyruvate kinase II; ppsA, p
isoenzymes F, G and H, respectively; aroB, DHQ synthase; aroD, DHQ dehyd
shikimate kinase II; aroA, EPSP synthase; aroC, chorismate synthase. pJLBaro
overproduction in this strain [10]. Continuous arrows represent unique reac
represent two or more enzymatic reactions or incomplete characterized re
of the SA pathway.produced by Roche Pharmaceuticals [3-5]. OSP prevents
the release of newly formed virus particles from influ-
enza virus types A and B, avian influenza virus H5N1
and, recently, human influenza virus H1N1. Since 1999,
Roche Pharmaceuticals increased the production of OSP
to ensure a significant reservoir in several countries in
anticipation of a possible pandemic influenza outbreak;
however, it has been estimated that in this scenario, the
production of the antiviral would be insufficient to cover
the requirements of the world population [6,7], particu-
larly in developing countries such as Mexico. The latest
human influenza outbreak, which appeared in Mexico in
2009, showed that production of OSP is clearly insuffi-
cient to satisfy the demand for this antiviral in an emer-
gency situation. Additionally, the main supply of SA for
OSP production is currently derived from the seeds of
Chinese star anise (Illicium verum). The supply of this
source is susceptible to vagaries of the weather. The star
anise plant takes around six-years from planting to bear
fruit but remains productive for a long time; additionally,
extraction and purification from its seeds results in low
yields. Thus, alternative biotechnological strategies with
engineered bacterial strains to produce SA have gained
relevance [4,5].
Metabolically engineered E. coli strains for SA produc-
tion include several genetic modifications in CCM such
as the introduction of an additional plasmid-copy
DAHPS AroFfbr, encoded by aroFfbr or DAHPS AroGfbr
(aroGfbr), the tktA gene encoding transketolase I, and
genes encoding enzymes from the SA pathway, including
the single or double inactivation of genes aroK and aroL,volved E. coli PB12.SA22 strain. Glucose transport and
ase (Glk), respectively. Genes and coded enzymes: galP, GalP; glk, Glk;
hosphoenolpyruvate synthase; aroF, aroG, aroH, DAHP synthase
ratase; aroE, shikimate dehydrogenase; aroK, shikimate kinase I; aroL,
GfbrtktA and pTOPOaroBaroD, indicate cloned plasmids for SA
tions catalyzed by one or more enzymes; dotted lines or arrows
actions. Cross line in the reaction of SHK to S3P indicates interruption
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genes encoding limiting enzymes of the pathway such as
aroB and aroE, resulting in an increased carbon flux
from the CCM intermediates PEP and E4P to the SA
pathway and accumulation of SA. The above-described
genetic modifications in specific E. coli genetic back-
grounds with additional modifications and grown under
diverse culture conditions have resulted in the successful
overproduction of SA with yields ranging from 0.08 to
0.42 mol SA/mol glucose [8-13] (Table 1).
Previous characterization of SA production in strain
PB12.SA22 in 0.5-L batch-fermentor cultures using com-
plex fermentation broth including 25 g/L of glucose and
15 g/L of YE showed a characteristic two-phase growth
behavior with an initially EXP growth with high μ while
consuming ~ one-third of the initially added glucose and
low level production of SA and other pathway interme-
diates. During the second growth phase, the μ decreased,
and the culture entered the STA phase despite the pres-
ence of abundant residual glucose in the supernatant
broth, whereas SHK pathway intermediate production
increased, continuously reaching its maximum until the
end of the fermentation (50 h). Interestingly, residual
glucose was depleted from supernatant culture during
the STA phase associated with SA production [10]. This
growth, glucose consumption and SA production behav-
ior suggest that during the EXP growth phase, strain
PB12.SA uses YE components to support growth and, as
consequence of the possible depletion of an essential nu-
trient component, cell ceases growth upon entering the
STA phase, where residual glucose was channeled by this
strain to produce SA and other pathway intermediates.
These data suggest the presence of important genetic
regulation and physiological differences during the EXP
and STA phases.Table 1 E. coli SA engineered overproducing strains, growth c
Strain/derivative Relevant characteristics Culture




SP1.1pts/pSC6.090B PTS− serA::aroB ΔaroL ΔaroK PTS− Ptacglf glk
aroFfbr tktA PtacaroE serA, glf1 glk2
10-L fed
with 25












ΔptsHIcrr ΔaroL Δarok ΔydiB knock-in of
T7-RNA-pol gene, pAOC-TGEFB aroE aroB,






PB12 lacI− aroK− aroL− pykF− Trc/aroB+
tktA+ aroGfbr+ aroE+ aroD+ zwf+
Batch fe
100 g/L




1Glucose facilitator (glf) and 2Glucokinase (glk) from Zymomonas mobilis; NR, Non-reGTA has been proven to be a powerful tool to study
regulation of cellular metabolism in response to specific
environmental conditions. To our knowledge, in relation
to SA production in E. coli, GTA has been used to eluci-
date byproduct formation in the SA production strain
W3110.shik1 under carbon and phosphate-limited (car-
bon-rich) chemostat conditions, suggesting that bypro-
duct formation under carbon limitation is explained by
the upregulation of a set of genes coupled to the SA
pathway [14]. In this study, we report the GTA in strain
PB12.SA22 during SA production in batch-fermentor
cultures using complex fermentation broth including
25 g/L of glucose and 15 of g/L YE. GTA was deter-
mined in this strain in the mid EXP growth phase (5 h),
at the beginning of the STA phase (STA1) (9 h) and in
the late STA phase (STA2) (44 h), and the comparison
of differentially upregulated genes was established during
the EXP/STA1, EXP/STA2 and STA1/STA2 phases to
correlate changes in the global expression profile and
growth, glucose consumption and SA production pro-
files in this strain.
Results
Growth and SA pathway intermediate production
Based on growth and glucose consumption profiles,
strain PB12.SA22 showed its characteristic two-phase
growth behavior [10], with an initial EXP growth phase
during the first 8 h of cultivation reaching an OD600 nm =
13.37 with a μ = 0.47 ± 0.002 h−1 and a qS = 3.34 ±
0.29 mmol glucose g DW−1 h−1. After 8 h of cultivation,
the culture reduced its growth rate even in the presence
of ~70% of initially added glucose in the fermentation
broth, and after 10 h of cultivation, the strain entered
into a pseudo-STA phase in which a low growth phase






atch cultures, mineral broth
g/L of glucose and 15 g/L of YE
52 0.18 [8]
-batch reactors, mineral broth
g/L of glucose and 15 g/L of YE
71 0.27 [8]
tat cultures using mineral broth
lucose limiting conditions
NR ~0.08 [9]
tch reactors, mineral broth with
f glucose and 15 g/L of YE
7 0.29 [10]
h fermentation, modified M9
, with 25 g/L of glycerol and
f YE
1.85 NR [11]
rmentation, mineral broth with
of glucose and 30 g/L of YE
43 0.42 [12]
broth with 10 g/L of glucose,
peptone, 1.24 g/L of proline
3.12 0.33 [13]
ported.
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strain completely consumed the residual glucose present
in the supernatant broth (showing a qS = 2.68 ± 0.5 mmol
glucose g DW−1 h−1). From this point to the end of the
fermentation, the biomass showed a slight reduction to
OD600 nm ~ 15 (Figure 2A). Interestingly, analysis of the
consumption profile of available supernatant aromatic
amino acids by HPLC showed that strain PB12.SA22 to-
tally consumed the tryptophan present in the YE during
EXP growth, reducing its growth when this aromatic
amino acid was completely depleted from the culture
supernatant (Figure 2B). SA production was detected inFigure 2 Growth, aromatic intermediates production, and
substrate consumption during batch fermentation cultures of
E. coli PB12.SA22 strain grown in complex broth. (A) Biomass
production (●) Glucose consumption (◆). (B) Residual Phenylalanine
(☐), Tyrosine (○), Tryptophan (△). (C) SA (▲), DHS (◆), GA (▼)
production. In panel A, numbers in parenthesis indicate the
sampling time of biomass for total RNA extraction used for
microarray analysis (1), (2) and (3) indicates samples collected at 5, 9,
and 44 h of cultivation, respectively.supernatant cultures in the EXP phase, but the highest
SA accumulation was observed during the last 24 h, ac-
cumulating 7.63 g/L SA at the end of fermentation
(50 h) (Figure 2C). The determined SA pathway bypro-
ducts, DAHP, DHS, and GA, appeared to be associated
with growth because their production remained rela-
tively constant after strain PB12.SA22 entered the STA
phase. SA production resulted in a yield of 0.31 mol SA/
mol glucose, and the total aromatic yield (the combined
yield of SA, DAHP, DHS, and GA) was 0.36 mol aro-
matic intermediates/mol glucose.
Global transcriptomic analysis during the EXP and STA
phases
GTA analysis was determined by triplicate in the middle
of the EXP phase (5 h), at the end of the EXP growth
phase and upon entering pseudo-STA phase (9 h)
(STA1) and at the end of the fermentation, or the late
STA phase (44 h) (STA2). Average expression data were
compared among EXP/STA1, EXP/STA2, and STA1/
STA2, using the expression data of 4070 genes from the
array of E. coli MG1655 included in the Affymetrix Gen-
eChip® E. coli Genome 2.0 by the RP method. For all ex-
pression data, the RP method calculated a FDR. Those
genes with an FDR value = 0 have the highest probability
of biological relevance [15,16]. To identify differentially
expressed (upregulated and downregulated) genes among
compared growth conditions, an FDR value cutoff ≤ 0.05
was used. This analysis resulted in the identification of the
significant upregulation of 43 genes and the downregula-
tion of 80 genes in EXP/STA1, the upregulation of 37
genes and the downregulation of 38 genes in EXP/STA2,
and the upregulation of 50 genes and the downregulation
of 47 genes in ST1/STA2 (Table 2). Among them, 22 com-
mon genes were found to be upregulated during the entire
fermentation process (EXP, STA1 and STA2). Biological
functions were assigned to upregulated genes according to
the EcoCyc database for E. coli strain MG1655 and
broadly grouped on the basis of GO terms [17].
Initial GTA data mining for upregulated genes in
EXP/STA1 (Table 3), EXP/STA2 (Table 4), and STA1/
STA2 (Table 5) comparisons resulted from the RP ana-
lysis from average transcription data for genes encoding
enzymes involved in glycolysis, PPP, TCA, and the glyox-
ylate shunt, acetate metabolism and gluconeogenic cap-
abilities in the EXP, STA1 and STA2 phases, showed that
genes encoding proteins of the CCM and SA pathways
were not significantly upregulated among performed com-
parisons (Additional file 1). However, significantly upregu-
lated genes detected during the EXP and STA phases
suggest important differences in sugar, amino acid, nu-
cleotide/nucleoside and ion transport; metabolic process,
particularly amino acid catabolism and biosynthesis; nu-
cleotide/nucleoside salvage; acid stress response and
Table 2 Differentially expressed genes during EXP/STA1, EXP/STA2 and STA1/STA2 comparisons during SA productiona
GO termsb EXP/STA1 EXP/STA2 STA1/STA2
UP DR UP DR UP DR
Transport 15 9 9 5 8 10
Amino acid metabolism 9 15 8 ND 16 4
Electron carrier activity 2 ND 1 ND 3 ND
Out of GOs 2 21 4 8 4 14
ATP catabolic/biosynthetic process 2 1 ND ND ND ND
Nucleotide/nucleoside metabolism 6 2 1 ND ND 2
Sulfur metabolism 2 ND 4 ND 2 ND
Stress response 1 12 2 6 5 3
Catalytic activity 1 ND 1 ND ND ND
Regulatory 2 7 4 7 4 4
Cell envelope ND 5 2 7 1 4
Structural molecule activity 1 ND 1 ND ND ND
Lipid metabolism ND 1 ND ND 3 ND
Other metabolic process ND 7 ND 5 4 6
Total gene number 43 80 37 38 50 47
aBased on resultant FDR value from the RP analysis equal or less to 0.05 [15]; b Biological functions were assigned according to the EcoCyc database for E. coli
strain MG1655 and broadly grouped on the basis of GO terms [17]. ND, Non-detected.
Cortés-Tolalpa et al. Microbial Cell Factories 2014, 13:28 Page 5 of 20
http://www.microbialcellfactories.com/content/13/1/28modification of the IM. A detailed list of those differen-
tially expressed genes in the EXP/STA1, EXP/STA2 and
STA1/STA2 comparisons, expression data and FDR
values information are presented in Additional file 1.
The role and the relationship with growth, substrate
consumption and SA production of relevant upregu-
lated genes during EXP/STA1, EXP/STA2 and STA1/
STA2 will be discussed below.
Discussion
Upregulation of genes involved in sugar transport
Genes encoding sugar transporters that were found to
be upregulated in the EXP/STA1 comparison included
the sugar porin LamB (lamB), the periplasmic binding
protein, the membrane subunit and the ATP binding
subunit components of the ABC maltose transport sys-
tem (malE and malFK, respectively) [17] and the GlpT
glycerol 3-P MFS transporter (glpT), whereas in the
EXP/STA2 comparison, the upregulation of the non-
specific OMP ompC (OmpC), a general porin and the
periplasmic binding protein of the maltose ABC
transporter (malE) was observed. A previous transcrip-
tomic analysis of our group determined by RT-qPCR in
cultures of the parental strain PB12 in M9 minimal
broth showed the upregulation of the galP gene, suggest-
ing that GalP protein is the main transporter used for
glucose import in this PTS− strain [18], as is the case in
a derived PB12 strain for L-Phe production grown in
M9 broth supplemented with 5 g/L of YE [19]. However,our GTA showed that in the SA-producing strain PB12.
SA22, the galP gene was not significantly upregulated
during EXP growth and the STA phase. This result was
also observed in GTA for the parental strain PB12 in the
same culture conditions (data not shown), suggesting
that in both strains grown in complex fermentation
broth for SA production, the OMP OmpC, LamB, and
the maltose ABC transporter, have an important role in
the transport of glucose because previous works re-
ported the participation of these proteins in the uptake
of glucose in E. coli [20-23]. All these genes were found
to be upregulated in the EXP and STA1 phases, associated
with the consumption of >30% of the initially added glu-
cose to the fermentation broth; however, only in the STA1/
STA2 comparison was detected the upregulation of ompC.
Differential expression of these transporters is in agree-
ment with the absence of glucose in the supernatant
culture observed at the middle STA phase (26 h). Interest-
ingly, the gene encoding the glycerol-3-P (G3P) MFS trans-
porter (GlpT) (glpT) was also detected upregulated during
the EXP/STA1 comparison but not during STA1/STA2.
G3P plays a major role in glycolysis and phospholipid bio-
synthesis in E. coli. G3P is transported by GlpT and is
reduced by aerobic or anaerobic G3P dehydrogenase
into dihydroxyacetone phosphate, which is converted into
fructose-1,6-diphosphate or glyceraldehyde-3-phosphate
and then enters the glycolysis pathway. In phospholipid
biosynthesis, G3P forms the backbone of all phospholipid
molecules and the polar groups of phosphatidylglycerol
Table 3 Average expression data of upregulated genes during EXP/STA1 comparison based on resultant FDR value
from the RP analysis equal or less to 0.05 in compared growth phases during SA production cultures
Gene Locus Protein namea Cellular functionb Averageexpression
asnA b3744 Asparagine synthetase A Amino acid metabolism 28.5470
aspA b4139 Aspartate ammonia-lyase Amino acid metabolism 5.7446
gcvH b2904 Glycine cleavage system H protein Amino acid metabolism 7.2457
gcvP b2903 Glycine decarboxylase Amino acid metabolism 12.2509
gcvT b2905 Aminomethyltransferase Amino acid metabolism 12.0966
putA b1014
Fused PutA DNA-binding transcriptional repressor/proline dehydrogenase/
1-pyrroline-5-carboxylate dehydrogenase
Amino acid metabolism 11.8149
sdaB b2797 L-serine deaminase II Amino acid metabolism 8.2308
tnaA b3708 L-cysteine desulfhydrase/tryptophanase Amino acid metabolism 60.3464
tnaL b3707 tna operon leader peptide Amino acid metabolism 91.7140
atpG b3733 ATP synthase F1 complex - gamma subunit ATP biosynthetic/catabolic process 5.5487
fecE b4287 Ferric dicitrate ABC transporter - ATP binding subunit ATP biosynthetic/catabolic process 7.0184
ompT b0565 OM protease VII (OM protein 3b) Catalytic activity 6.0698
groS B4142
Polypeptide: GroES, chaperone binds to Hsp60 in pres. Mg-ATP, suppressing its
ATPase activity
Cell processes 5.9806
cyoB b0431 Cytochrome bo terminal oxidase subunit I Electron carrier activity 6.3920
cyoD b0429 Cytochrome bo terminal oxidase subunit IV Electron carrier activity 6.6316
gpt b0238 Xanthine-guanine phosphoribosyltransferase Nucleotide/nucleoside metabolism 6.4026
guaC b0104 GMP reductase Nucleotide/nucleoside metabolism 6.7694
pyrB b4245 Aspartate carbamoyltransferase, catalytic subunit Nucleotide/nucleoside metabolism 10.8487
rihA b0651 Ribonucleoside hydrolase 1 (pyrimidine-specific) Nucleotide/nucleoside metabolism 5.9568
upp b2498 Uracil phosphoribosyltransferase Nucleotide/nucleoside metabolism 5.4210
yliF b0834 Predicted diguanylate cyclase Nucleotide/nucleoside metabolism 5.6595
nlpA b3661 Lipoprotein-28 Out of GOs 7.2359
yieI b3716 Predicted IM protein Out of GOs 6.6363
gcvB b4443 GcvB small regulatory RNA Regulatory 7.4984
yeeN b1983 Conserved protein Regulatory 5.3142
rihA b4142 GroES, chaperone binds to Hsp60 in pres. Mg-ATP, suppressing its ATPase activity Stress response 5.9806
cyoE b0428 Heme O synthase Structural molecule activity 5.9183
cysC B2750 Adenylylsulfate kinase Sulfur metabolism 7.0141
cysH b2762 3′-Phospho-adenylylsulfate reductase Sulfur metabolism 11.2772
cirA b2155 OM receptor involved in uptake of ferric dihyroxybenzoylserine Transport 9.4700
fecA b4291 Ferric citrate OMP FecA Transport 19.9369
fecB b4290 Ferric dicitrate ABC transporter - periplasmic binding protein Transport 14.5864
fruB b2169 Fructose PTS permease - FruB subunit Transport 5.8528
glpT b2240 GlpT glycerol-3-P MFS transporter Transport 8.6190
lamB b4036 Phage lambda receptor protein; maltose high-affinity receptor Transport 18.0411
livK b3458 Leucine ABC transporter - periplasmic binding protein Transport 6.0726
malE b4034 Maltose ABC transporter - periplasmic binding protein Transport 174.0512
malF b4033 Maltose ABC transporter - membrane subunit Transport 19.1719
malK b4035 Maltose ABC transporter - ATP binding subunit Transport 14.8026
nmpC b0553 OMP protein; locus of qsr prophage Transport 11.7561
proX b2679 Glycine betaine/proline ABC transporter - periplasmic binding protein Transport 7.3363
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Table 3 Average expression data of upregulated genes during EXP/STA1 comparison based on resultant FDR value
from the RP analysis equal or less to 0.05 in compared growth phases during SA production cultures (Continued)
sbp b3917 Sulfate/thiosulfate ABC transporter - periplasmic binding protein Sbp Transport 11.2712
tnaB b3709 TnaB tryptophan ArAAP transporter Transport 9.9672
tsx b0411 Nucleoside channel; receptor of phage T6 and colicin K Transport 6.2757
aRetrieved from EcoCyc database, bBiological functions were assigned according to the EcoCyc database for E. coli strain MG1655 and broadly grouped on the
basis of GO terms [17].
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PB12.SA22 is intriguing because G3P was not present dur-
ing the SA production cultures. GlpT could be involved
in phospholipid biosynthesis during the EXP/STA1
comparison because it was previously reported, and in-
direct evidence suggests that GlpT expression may be
regulated by a byproduct from the glycerolipid biosyn-
thetic pathway [24].
Upregulation of genes involved in the amino acid
transport and metabolism
During the EXP/STA1 comparison, livK, encoding a
subunit of the ABC transporter for leucine, and tnaB
(part of the tnaCAB operon) encoding the TnaB trypto-
phan ArAAP transporter, which is proposed to be in-
volved in tryptophan scavenging [25], were upregulated.
The EXP/STA2 comparison revealed the upregulation of
the genes for the putative membrane protein and the
ATP binding components of the BppBCDF dipeptide
ABC transporter (dppB and dppF), which is associated
with the transport of proline-glycine as source of pro-
line, histidine-glutamic acid, and leucine-tryptophan
[26,27]; the putative membrane protein of the murein
tripeptide ABC transport system (oppB), which can
transport oligopeptides of up to five residues in length
as well as recycle cell-wall peptides, but it has been re-
ported to lack affinity for free amino acids [28-31]; and
the complete glycine betaine/proline ABC transporter
encoded by the proVWX operon [17]. Expression of this
operon was reported to substantially increase at high
osmolarity to scavenge glycine, betaine, proline, taurine,
ectoine, carnitine as the precursor for betaine, and cho-
line to achieve high intracellular concentrations of these
osmoprotectants [32-34]. During the STA1/STA2 com-
parison, the periplasmic binding protein of the arginine
ABC transporter (artJ); the 4-aminobutyrate antiporter
glutamic acid GadC (gadC), a member of the APC
superfamily of amino acid transporters [35]; and the in-
tegral membrane subunit and the ATP-binding compo-
nent of the lysine/arginine/ornithine ABC transporter
and the histidine ABC transporter (hisM and hisP, re-
spectively) were found to be upregulated [17].
Differential upregulation of those genes encoding pep-
tide and amino acid transporters during the entire fer-
mentation process suggests that during batch culture forSA production, strain PB12.SA22 imports the substrates
that are available in the fermentation broth into the cell
because they are supplied by YE, which contains 6%
amino nitrogen, supplying peptides and 18 of the 20
proteinogenic amino acids (with the exception of aspara-
gine and glutamine) [36]; however, differential upregula-
tion of amino acid transporters observed during the
EXP, STA1 and STA2 phases suggests a possible differ-
ential amino acid requirement by the cell during the
fermentation process, particularly for leucine and trypto-
phan during the EXP/STA1 comparison and leucine, ar-
ginine, glutamic acid, lysine and histidine during the
STA1/STA2 comparison. Amino acid availability in the
fermentation broth provided by YE almost certainly alle-
viates the cellular requirements because YE contains all
these amino acids [36]. Finally, in the EXP/STA1 and
EXP/STA2 comparisons, ompT, encoding protease VII
was upregulated; this protein is capable of cleaving sev-
eral peptides at the center of paired basic residues but
not at single basic residues, suggesting a distinct mech-
anism for trypsin-like proteases [17]. Although OmpT is
not involved in transport, it is possibly related to peptide
assimilation in strain PB12.SA22 during SA production.
Together with the upregulation of genes encoding
peptide and amino acid transporters, several genes en-
coding enzymes involved in amino acid catabolic or
biosynthetic pathways were differentially upregulated
during the EXP growth and STA phases. Among biosyn-
thetic genes encoding the enzymes involved in the
complete cysteine biosynthesis from sulfate, CysD, CysC,
CysH (cysD, cysC and cysH, respectively) [17] were
found upregulated during the EXP/STA2 and STA1/
STA2 comparisons, while CysJ (cisJ), encoding sulfite
reductase (NADPH), which catalyzes the 6-electron re-
duction of sulfite to sulfide, one of several activities ne-
cessary for the biosynthesis of cysteine from sulfate [17],
was found to be upregulated only in the EXP/STA1
comparison. During the EXP/STA2 comparison, we de-
tected the upregulation of those genes encoding hydro-
xymethyltransferase (glyA) involved in the conversion
of serine to glycine; the enzyme cysteine synthase A
(cysK) catalyzing the conversion of O-acetyl-L-serine to
L-cysteine [37-39] (although, in the absence of a sulfur
source, this enzyme catalyzes the slow conversion of O-
acetyl-L-serine into pyruvate + acetate + ammonia, or the
Table 4 Average expression data of upregulated genes during EXP/STA2 comparison based on resultant FDR value
from the RP analysis equal or less to 0.05 in compared growth phases during SA production cultures
Gene Locus Protein namea Cellular function GOb Averageexpression
ykfE b0220 (ivy) Protein: inhibitor of vertebrate C-type lysozyme Amino acid metabolism 29.2978
cysK b2414 Enzyme: cysteine synthase A Amino acid metabolism 83.0796
gcvH b2904 Polypeptide: glycine cleavage system H protein Amino acid metabolism 30.4955
gcvP b2903 Enzyme: glycine decarboxylase Amino acid metabolism 33.3045
gcvT b2905 Enzyme: aminomethyltransferase Amino acid metabolism 38.3509
gdhA b1761 Enzyme: glutamate dehydrogenase Amino acid metabolism 20.9785
glyA b2551 Enzyme: serine hydroxymethyltransferase Amino acid metabolism 23.7380
tnaA _b3708 L-cysteine desulfhydrase/tryptophanase Amino acid metabolism 139.6125
tnaL b3707 tna operon leader peptide Amino acid metabolism 62.9786
ompT b0565 Enzyme: OM protease VII (OM protein 3b) Catalytic activity 35.7201
fimC b4316 Polypeptide: periplasmic chaperone, required for type 1 fimbriae Cell envelope 63.3469
fimD b4317 Polypeptide: OM protein; export and assembly of type 1 fimbriae Cell envelope 25.6637
nlpA b3661 Polypeptide: lipoprotein-28 Cell envelope 48.3194
ydiQ b1697 Polypeptide: putative subunit of YdiQ-YdiR flavoprotein Electron carrier activity 29.9950
nrdA b2234 Protein: ribonucleoside diphosphate reductase 1, α subunit dimer Nucleotide/nucleoside
metabolism
37.6063
yciW b1287 Polypeptide: predicted oxidoreductasePolypeptide: predicted oxidoreductase Out of GOs 116.1438
yieI b3716 (cbrB) Polypeptide: predicted IM protein Out of GOs 31.9090
yeeN b1983 Polypeptide: conserved protein Regulatory 22.0828
yhiE b3512 (gadE) Polypeptide: GadE DNA-binding transcriptional activator Regulatory 46.2077
yhiW b3515 (gadW) Polypeptide: GadW DNA-binding transcriptional dual regulator Regulatory 37.7545
hdeA b3510 Protein: HdeA dimer, inactive form of acid-resistance protein Stress response 32.4174
hdeB b3509 Polypeptide: acid stress chaperone Stress response 56.2185
b0023 b0023 Polypeptide: 30S ribosomal subunit protein S20 Structural molecule activity 45.8728
cysC b2750 Enzyme: adenylylsulfate kinase Sulfur metabolism 52.8463
cysD cysD Polypeptide: CysD Sulfur metabolism 236.2573
cysH b2762 Enzyme: 3′-phospho-adenylylsulfate reductase Sulfur metabolism 194.5029
cysJ b2764 Enzyme: sulfite reductase, flavoprotein subunit complex Sulfur metabolism 62.3545
ydjN b1729 Polypeptide: predicted transporter Transport 43.4944
dppB b3543 Polypeptide: dipeptide ABC transporter - putative membrane subunit Transport 23.0830
dppF b3540 Polypeptide: dipeptide ABC transporter - putative ABC binding subunit Transport 32.6107
fecA b4291 Polypeptide: ferric citrate OMP FecA Transport 23.6130
malE b4034 Maltose ABC transporter - periplasmic binding protein Transport 230.4651
ompC b2215 Transporter: OMP C Transport 61.2832
oppB b1244
Polypeptide: murein tripeptide ABC transporter/peptide ABC transporter - putative
membrane subunit
Transport 44.3550
proV b2677 Polypeptide: glycine betaine/proline ABC transporter - ATP binding subunit Transport 34.7488
proW b2678
Polypeptide: glycine betaine/proline ABC transporter - membrane subunitPolypeptide:
glycine betaine/proline ABC transporter - membrane subunit
Transport 35.6683
proX b2679 Polypeptide: glycine betaine/proline ABC transporter - periplasmic binding protein Transport 48.2957
aRetrieved from EcoCyc database, bBiological functions were assigned according to the EcoCyc database for E. coli strain MG1655 and broadly grouped on the
basis of GO terms [17].
Cortés-Tolalpa et al. Microbial Cell Factories 2014, 13:28 Page 8 of 20
http://www.microbialcellfactories.com/content/13/1/28
Cortés-Tolalpa et al. Microbial Cell Factories 2014, 13:28 Page 9 of 20
http://www.microbialcellfactories.com/content/13/1/28conversion of O-acetyl-L-serine into simple serine [40];
and glutamate dehydrogenase (gdhA) involved in the
NADPH-dependent amination of α-ketoglutarate to
yield L-glutamate. Catabolic genes upregulated during
the EXP/STA1 and EXP/STA2 comparisons included
tnaCA (part of the tnaCAB operon), which encodes the
tryptophanase leader peptide and the tryptophanase in-
volved in tryptophan degradation to indole + PYR + am-
monia + H+. During the EXP/STA1 and EXP/STA2
comparisons, the entire glycine cleavage system (GCV)
(gcvTHP operon), a multienzyme complex catalyzing the
reversible oxidation of glycine, yielding carbon dioxide,
ammonia, 5,10-methylenetetrahydrofolate and a reduced
pyridine nucleotide [17,41] was also upregulated. Tetra-
hydrofolate serves as a recipient for C1 units generated
during glycine cleavage to form the methylene group,
which are of central physiological importance, as will be
discussed below [41-43].
Another group of upregulated genes found during the
EXP/STA1 comparison, were the genes involved in am-
monia dependent conversion of aspartate to asparagine
(amino acid not supplied by YE), by asparagine synthe-
tase (asnA) and the catabolic genes involved in the
conversion of aspartate to Fum + ammonia + H+ by
aspartate ammonia-lyase (aspA), which is the first step
in the proline degradation pathway to glutamic acid by
proline dehydrogenase (putA), and in serine degradation
to PYR + ammonia + H+ by L-serine deaminase II (sdaB)
[17]. Notably, a group of upregulated genes during the
STA1/STA2 comparison include genes encoding the en-
tire arginine biosynthesis pathway and the ornithine bio-
synthesis pathway (argA, argCBH, argG, argD and argI)
and carbamoyl phosphate synthetase (carAB), which cat-
alyzes the first committed step in the biosynthetic path-
ways for the production of arginine and pyrimidine
nucleotides. The small subunit of this enzyme (carA)
also hydrolyzes glutamine to glutamate and ammonia
[44]. ilvG_1 and ilvG_2, part of the ilvLXG_1G_2MEDA
operon [45], are pseudogenes encoding subunits of acet-
ohydroxybutanoate synthase / acetolactate synthase, an
essential enzyme that catalyzes the biosynthesis of α-
aceto-α-hydroxybutyrate for the isoleucine pathway and
of α-acetolactate for the valine biosynthesis when E. coli
K-12 was grown on acetate or oleate as the sole carbon
source [46]. Other genes upregulated in the STA1/STA2
comparison encode cobalamin-independent homocysteine
transmethylase (metE), which catalyzes the final step of
de novo methionine biosynthesis in the absence of ex-
ogenously supplied vitamin B12 (cobalamin); α-keto
glutarate reductase/D-3-phosphoglycerate dehydrogen-
ase (serA), which catalyzes the first committed step in
the biosynthesis of L-serine from 3-P-glycerate; and glu-
taminase (ybaS), which catalyzes the degradation of glu-
tamine to yield glutamate [17].The main cellular role of amino acids is as structural
blocks for the synthesis of proteins. Their availability de-
termines the growth capabilities of cells, thereby defin-
ing the extent of the EXP growth phase, particularly for
auxotrophic strains. Because strain PB12.SA22 is auxo-
trophic for aromatic amino acids due to the deletion of
the aroK and aroL genes, its growth depends of the
extracellular availability of these essential amino acids
present in YE. As it was observed in Figure 2B, when
tryptophan was depleted from the fermentation broth,
this strain decreased its μ even in the presence of <70%
residual glucose, showing that the availability of this
amino acid is a determinant factor for growth capabil-
ities of strain PB12.SA22 after 9 h of fermentation, al-
though the strain could use additional (non-specified)
carbohydrates supplied by YE (17.5%) [36] or other
amino acids as possible carbon sources.
Based on our GTA data, differential upregulation of
genes encoding glycine transport components (operon
proVWX) and the genes involved in the synthesis of
serine from 3-P-glycerate and its subsequent transform-
ation to glycine by upregulation of glyA and serA, no differ-
ential expression of serB and serC genes (Additional file 1)
and the upregulation encoding genes for the GCV sug-
gest an important role for these two amino acids
in strain PB12.SA22 because they are most likely used
additionally as protein components to yield C1 units,
which provide precursors for diverse important cellular
process; indeed, it was reported that during growth on
glucose, E. coli employs ~ 15% of the carbon assimilated
in serine and its metabolites, such as the synthesis of
cysteine, phospholipids, and glycine, whereas glycine is
used in the synthesis of purines and heme-containing
compounds. C1 units derived from serine and glycine
are used in the synthesis of purines, histidine, thymine,
pantothenate, and methionine and in the formylation of
the aminoacylated initiator fMet-tRNA used to start
translation in E. coli. In turn, these compounds are in-
volved in other essential cellular process demanding the
supply of C1 units [41,42], suggesting that particularly
in the EXP/STA1 and EXP/STA2 comparisons C1 units
derived from serine and glycine could be channeled for
the biosynthesis of diverse cellular components used
mainly for cellular maintenance of strain PB12.SA22
(Figure 3).
Interestingly, the genes encoding the complete biosyn-
thetic pathway for arginine from glutamate ArgA, ArgB,
ArgC, ArgD, ArgE, ArtI, ArgG and ArgH (argA, argB,
argC, argD, argE, argF, argG and argH, respectively) and
from bicarbonate to carbamoyl-phosphate (carAB) [17]
were found to be upregulated in the STA1/STA2 com-
parison, whereas they were downregulated during the
EXP phase (Additional file 1), suggesting an important
role of this amino acid during the STA phase distinct
Table 5 Average expression data of upregulated genes during STA1/STA2 comparison based on resultant FDR value
from the RP analysis equal or less to 0.05 in compared growth phases during SA production cultures
Gene Locus Protein namea Cellular function GOb Averageexpression
argA b2818 Acetylglutamate synthase Amino acid metabolism 87.9837
argB b3959 N-acetylglutamate kinase Amino acid metabolism 45.8143
argC b3958 N-acetylglutamylphosphate reductase Amino acid metabolism 53.4932
argD b3359 N-succinyldiaminopimelate-aminotransferase/acetylornithine transaminase Amino acid metabolism 21.9053
argE b3957 Acetylornithine deacetylase Amino acid metabolism 18.7485
argG b3172 Argininosuccinate synthase Amino acid metabolism 65.2192
argH b3960 Argininosuccinate lyase Amino acid metabolism 23.7859
argI b4254 Ornithine carbamoyltransferase chain I Amino acid metabolism 33.2672
carA b0032 Polypeptide: CarA Amino acid metabolism 107.7785
carB b0033 Polypeptide: CarB Amino acid metabolism 23.9781
ilvG_1 b3767 Acetolactate synthase II, large subunit, N-ter fragment Amino acid metabolism 75.4038
ilvG_2 b3768 Acetolactate synthase II, large subunit, N-ter fragment Amino acid metabolism 24.6648
ilvM b3769 Polypeptide: IlvM Amino acid metabolism 16.9332
metE b3829 Cobalamin-independent homocysteine transmethylase Amino acid metabolism 59.0097
serA b2913 α-Ketoglutarate reductase/D-3-phosphoglycerate dehydrogenase Amino acid metabolism 15.4266
ybaS b0485 Glutaminase Amino acid metabolism 27.4637
fimC b4316 Periplasmic chaperone, required for type 1 fimbriae Cell envelope 20.5382
ydiQ b1697 Putative subunit of YdiQ-YdiR flavoprotein Electron carrier activity 32.4583
ydiR b1698 Putative subunit of YdiQ-YdiR flavoprotein Electron carrier activity 32.3715
ydiT b1700 Putative ferredoxin Electron carrier activity 28.0548
arnB b2253 UDP-L-Ara4O C-4′ transaminase Lipid metabolism 20.7697
arnC b2254 Undecaprenyl phosphate-L-Ara4FN transferase Lipid metabolism 33.1058
yhiD b3508 Predicted Mg(2+) transport ATPase Lipid metabolism 52.2858
narY b1467 Nitrate reductase Z, β subunit Other metabolic process 18.7104
narZ b1468 Nitrate reductase Z, α subunit Other metabolic process 13.4094
yciE b1257 Conserved protein Other metabolic process 18.9020
ydiS b1699 Putative flavoprotein Other metabolic process 20.0646
ygdI b2809 Putative lipoprotein Out of OGs 15.8477
slp b3506 Starvation lipoprotein Out of OGs 16.3895
ybaY b0453 Predicted OM lipoprotein Out of OGs 31.4852
yhjR b3535 Conserved protein Out of OGs 17.5298
yhiE b3512 GadE DNA-binding transcriptional activator Regulatory 224.6027
yhiF b3507 Polypeptide: predicted DNA-binding transcriptional regulator Regulatory 33.7016
yhiW b3515 GadW DNA-binding transcriptional dual regulator Regulatory 33.4367
ykfE b0220 Inhibitor of vertebrate C-type lysozyme Regulatory 40.8144
gadB b1493 Glutamate decarboxylase B Stress response 94.5462
hdeA b3510 HdeA dimer, inactive form of acid-resistance protein Stress response 125.3695
hdeB b3509 Acid stress chaperone Stress response 104.9129
hdeD b3511 Acid-resistance membrane protein Stress response 140.6337
katE b1732 Heme d synthase/hydroperoxidase Stress response 15.6533
cysD b2752 Polypeptide: CysD Sulfur metabolism 34.5193
cysH b2762 3′-Phospho-adenylylsulfate reductase Sulfur metabolism 15.6801
hisP b2306 Lysine/arginine/ornithine ABC transporter/histidine ABC transporter - ATP binding subunit Transport 17.8485
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Table 5 Average expression data of upregulated genes during STA1/STA2 comparison based on resultant FDR value
from the RP analysis equal or less to 0.05 in compared growth phases during SA production cultures (Continued)
potG b0855 Putrescine ABC transporter - ATP binding subunit Transport 18.0562
artJ b0860 Arginine ABC transporter - periplasmic binding protein Transport 120.3908
gadC b1492 Glutamic acid: 4-aminobutyrate antiporter Transport 28.9528
hisM b2307 Lysine/arginine/ornithine ABC transporter/histidine ABC transporter - membrane subunit Transport 44.5442
narU b1469 NarU MFS nitrate/nitrite antiporter Transport 62.1767
ompC b2215 OMP C Transport 37.5373
yggB b2924 Mechano sensitive channel MscS Transport 22.3863
aRetrieved from EcoCyc database, bBiological functions were assigned according to the EcoCyc database for E. coli strain MG1655 and broadly grouped on the
basis of GO terms [17].
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available in the supernatant broth because it is also sup-
plied by YE (3.03%) [36]. This amino acid is transported
by the arginine ABC transporter ArtPMQJI (argP, argM,
argQ, argJ and argI, respectively); however, among these
genes, artI encodes the periplasmic binding component
and is the unique found upregulated gene of this trans-
porter, whereas the remaining genes were found without
changes in their expression, suggesting that in addition
to the upregulation of genes encoding the complete bio-
synthetic pathway for arginine from glutamate and bicar-
bonate, this amino acid is also transported from the
fermentation broth during the STA phase. Arginine can
be degraded by two pathways, the arginine succinyl-
transferase (AST) pathway yielding succinate, which en-
ters to TCA, and the arginine decarboxylase/agmatinase
pathway, which also yields succinate. This last pathway
yields the intermediate putrescin, which connects argin-
ine degradation with the biosynthetic pathways of the
polyamines putrescine, spermidine, cadaverine and ami-
nopropylcadaverine [17]. Interestingly, unlike E. coli K-12,Figure 3 Proposed metabolic and physiologic traits of E. coli PB12.SA
GTA. OM, IM, Glycolysis, PPP, TCA and SA pathway are illustrated schemati
arrows indicate suggested or unknown mechanisms.wild-type E. coli strains are unable to use L-arginine as
a carbon source, but they can use this amino acid as a
nitrogen source [47,48]. Based on this evidence, our tran-
scriptomic data suggest that arginine could be used by
strain PB12.SA22 as a source of succinate to recycle C
through TCA or as a source for polyamines during the
STA phase for SA production. However, data mining of
the RP method analysis for microarray data comparison
between STA1/STA2 showed that none of the genes of
the arginine AST degradation (operon astCADBE) and ar-
ginine decarboxylase/agmatinase (adiA, speB, speF, puuAP,
puuDRCBE and sad) pathways were significantly upregu-
lated (Additional file 1). Polyamines are reported as neces-
sary for cell growth because they are major polycations in
cells, together with Ca2+ and Mg2+. Polyamines and Mg2+,
which are present in higher free concentrations than Ca2+,
can bind to intracellular polyanions such as nucleic acids
and ATP to modulate their function [49]. Polyamines have
also been associated with stabilizing membranes and
stimulating several enzymes [17], and furthermore, spermi-
dine was found to donate a portion of its molecule for the22.based on relevant upregulated genes during EXP and STA
cally. Arrows indicate the direction of transport or reaction; dotted
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that plays a crucial role in cell proliferation [50]. Because
strain PB12.SA22 ceased EXP growth by hour 9 of cultiva-
tion and entered a pseudo STA phase until the end of the
fermentation, it is unlikely that arginine could be used as a
polyamine precursor, suggesting that it could be used to
supply succinate to TCA, through the gluconeogenic cap-
abilities developed by strain PB12 [18,51], to make PEP
available for use in SA production, particularly during the
late STA phase in the absence of glucose (Figure 3).
Possible associations between amino acid transport,
catabolism and pH stress response
Amino acids such as aspartate, serine and tryptophan
could be used potentially by E. coli as carbon sources
under certain growth conditions. Catabolism of aspartate
by aspartate ammonia-lyase, AspA (aspA) yields Fum +
ammonia +H+; catabolism of L-serine by serine deami-
nase, SdaB (sdaB) yields PYR + ammonia + H+; whereas
the catabolism of tryptophan catalyzed by tryptophanase
(tnaA) yields PYR + ammonia + indole + H+. In turn, fu-
marate and PYR could fuel TCA or increase intracellular
PYR availability, respectively [17]. However, amino acid
deamination is a metabolic process displayed by E. coli to
contend with alkaline stress that supplies carbon for bac-
terial growth under this condition, particularly when
growing in complex peptide-rich media. As cell density in-
creases, extracellular pH alkalinizes and released ammonia
is deprotonated and volatilized, whereas the C skeleton is
channeled into acids [52-54]. Based on our transcriptomic
data showing the upregulation of genes such as tnaA,
aspA and sdaB during the EXP and STA phases, we
propose that intracellular availability of amino acids such
as aspartate, cysteine and tryptophan, either by importing
them from the extracellular environment (as they are pro-
vided by YE) or by interconversion from other sources,
e.g., cysteine from O-acetyl-L-serine by CysK (cysK) [17]
(also upregulated during the EXP/STA2 comparison),
have an important role in a possible cellular response of E.
coli PB12.SA22 during SA production to extracellular
alkalinization because upregulation of tnaA, aspA and
sdaB suggests that their respective enzymes deaminate
aspartate, cysteine and tryptophan to PYR or Fum. In
addition to the upregulation of these genes, a previous re-
port indicates that as a consequence of cellular exposure
to neutral pH conditions, E. coli 3110 showed a higher
expression of 93 genes (grouped as the neutral high
expressed cluster showing highest expression at pH 7.0
and lower expression at both pH extremes), including
fecA, fecB, fecE, lamB, livK, malE, malF and malK [55].
Interestingly, all these genes were found to be upregulated
in strain PB12.SA22 in the EXP/STA1 comparison, with
exception of malE, which was also upregulated in the
STA1/STA2 comparison.Several genes encoding proteins involved in the AR in
E. coli were found to be upregulated during the EXP and
STA phases, including the chaperone-based AR proteins
HdeA and HdeB, which belong to the hdeAB acid stress
operon involved in the periplasmic acid stress response
that prevent periplasmic-protein aggregation at acidic
pH; the IM protein HdeD (hdeD), which is required for
acid resistance [56], was found to be upregulated during
the STA1/STA2 comparison, and GadB and GadC
(gadBC operon) were upregulated in the STA1/STA2
phases and are components of the Gad system (the glu-
tamate decarboxylase system), the major AR system in
E. coli under extreme acidic conditions [17]. GadB (to-
gether with GadA) are pyridoxal 5′-phosphate (PLP)-
dependent enzymes that convert glutamate to γ-amino
butyric acid (GABA) and carbon dioxide in a reaction
that consumes a cytoplasmic proton. GABA is trans-
ported out of the cell by the IM antiporter GadC in ex-
change for more extracellular glutamate [57], whereas
GadW is a transcriptional dual regulator (yhiW or
gadW) [17,57,58]. Several regulatory genes of the Gad
system (gadA, gadE, gadW and gadX), as well as the
chaperone-related genes hdeABD, were placed in a
unique cluster termed the acid fitness island [59], but
interestingly, more genes in this island were found to
participate in acid resistance, including the OM lipopro-
tein Slp (slp) and the transcriptional regulator YhiF
(yhiF) (both genes were upregulated in the STA1/STA2
comparison in our transcriptomic study), which are re-
quired to protect cells against excreted toxic metabolites,
including the accumulated anions of dissociated weak
acids after growth at low pH such as lactate, succinate,
and formate [57]. Additionally, GadE serves as the global
transcriptional activator for many genes involved in
stress response, glutamante biosynthesis, and in the bio-
synthesis of membrane components. Auto-induction of
GadE requires the alternative sigmaS factor responsible
for the transcription of many genes in the STA phase
and another unidentified factor, whereas P2 and P3 of
gadE are activated by GadX (or YhiX) and GadW (or
YhiW) during the STA phase [57].
The simultaneous upregulation of genes encoding pro-
teins involved in acid pH stress response with the upregu-
lation of catabolic amino acid pathway to revert an
apparent alkalinization has been reported to have a com-
mon connection, the protein GadB [52]. As was discussed
above, high extracellular pH induces transcription of
several genes encoding enzymes generating ammonia,
such as TnaA, CysK, SdaB and AsnA, by deaminating
tryptophan, serine, cysteine and aspartate, respectively. Ex-
pression of gadB is controlled by sigmaS during the STA
phase in minimal growth medium; however, induction of
this gene has been observed during growth in complex
medium between pH 5.5 and 8.0 [52,55,60]. Induction of
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ported due to the presence of glutamate in YE. Glutamate
and glutamine appear to activate a preformed RpoS-
dependent system that is produced by entry into the STA
phase [60]. According to this observation, simultaneous
upregulation of the AR Gad system associated with the in-
duction of genes involved in alkaline pH stress observed
during SA production could be induced by the presence
of glutamate in YE, which is transported by GadC. Add-
itionally, upregulation of hdeAB during the EXP/STA2
comparison can be explained by the inductor effect of glu-
tamate because these genes are also activated by GadE
and GadW [17].
It has been established that the OM envelope and the
periplasmic space are cellular compartments exposed es-
sentially to extracellular pH [52]. In bacterial strains
used for metabolite production such as PB12.SA22, dur-
ing SA production, it is not surprising that the periplas-
mic side of the IM, the periplasmic space and the inner
side of the OM could be exposed to low acid stress be-
cause SA is exported from the cytoplasm and then dif-
fuses into the extracellular environment; conversely, the
external side of the OM could be exposed to low alka-
line stress as a consequence of the addition of NH4OH
to maintain fermentor pH ≅ 7.0. This supposition makes
sense given the observed upregulation of genes involved
in acid pH stress response, simultaneous with the upreg-
ulation of the deaminating amino acid pathway to re-
verse an apparent alkalinization during SA production
by strain PB12.SA22 (Figure 3).
Upregulation of genes involved in iron and sulfur
transport and its metabolism
Iron and sulfur seems to play an important physiological
role during SA acid production by strain PB12.SA22 be-
cause some genes encoding transporters for these ions
were found to be upregulated. Among these, fecBE was
found to be upregulated in the EXP/STA1 comparison,
and fecA was observed in the EXP/STA2 comparison.
The fecABC operon genes are located in the fecABCDE
operon and encode the ferric citrate OMP FecA (fecA),
the IM ferric dicitrate ABC transporter (fecB), and the
ATP binding component (fecE) [61]. Additionally, it was
found to be upregulated in the EXP/STA1 comparison
the OM receptor Cir (cirA), a TonB dependent iron-
siderophore complex involved in iron uptake and regu-
lated by both cellular iron content and growth [62]. Re-
garding sulfur, the upregulation of the periplasmic
binding protein (Sbp) sulfate/thiosulfate ANC trans-
porter (sbp) in the EXP/STA1 comparison was observed,
which is associated with the transport both of sulfate
and thiosulfate that are used as sulfur sources [63]. Fi-
nally, in the STA1/STA2 comparison, we also found that
the genes narU, narZ and narY (part of the narUZYWVoperon) were upregulated, which encode the nitrite/ni-
trate transporter (narU) and the σ and β subunits of the
IM located nitrite/nitrate reductase (narZ and narY,
respectively).
Iron is essential for the growth of E. coli, as is empha-
sized by the variety of processes in which iron-
containing proteins take part, including their structural
association to proteins involved in electron transport or
playing important roles, particularly for iron-sulfur pro-
teins involved in amino acid and pyrimidine biosynthesis
(glutamate synthase, dihydroorotate dehydrogenase), and
the TCA (aconitase, succinate dehydrogenase), as well as
in electron transport (ferredoxin) and non-heme, non-
iron-sulfur proteins required for DNA synthesis (ribonu-
cleotide reductase), protection from superoxide radicals
(superoxide dismutase), and interestingly, aromatic
amino acid biosynthesis (DAHP synthase) [64]. Exogen-
ous ferric citrate (supplied in the fermentation broth for
SA production as ammonium iron (III) citrate), is trans-
ported across the OM by FecA, and a signal is transmit-
ted across the OM to the IM protein FecR, which
transmits the signal across the IM, thereby activating
(through the sigma70 factor) the cytoplasmic family pro-
tein FecI, which directs RNA polymerase to express the
fecABCDE operon [17,61,65].
Upregulation of genes involved in nucleotide/nucleoside
transport and biosynthesis
During the EXP/STA1 comparison, upregulation was ob-
served for the gene encoding OMP Tsx (tsx), a protein
that has been proposed to function in vivo as a pore that
specifically facilitates the permeation of nucleosides and
deoxynucleosides across the OM due to its specificity for
free nucleobases or monophosphate nucleosides [22,66].
Regarding nucleotide/nucleoside metabolism, were found
upregulated genes involved in pyrimidine ribonucleoside
salvage, rihA and upp encoding ribonucleoside hydrolase
1 (pyrimidine-specific) and uracil phosphoribosyltransfer-
ase, respectively, which catalyze the sequential conversion
of uridine→ uracil→ UMP [17]. Regarding pyrimidine ri-
bonucleotide de novo biosynthesis, was found upregulated
the gene pyrB encoding the catalytic subunit of the aspar-
tate carbamoyltransferase, an enzyme catalyzing the con-
version of L-asparte + carbamoyl-P to N-carbamoyl-L-
aspartate in reactions involved in the biosynthesis of
UMP in this pathway [17]. Finally, regarding the aden-
ine and adenosine salvage pathway, upregulation was
detected for the gpt gene, encoding xanthine-guanine
phosphoribosyltransferase, which catalyzes the conver-
sion of hypoxanthine to IMP, a common precursor for
the guanosine and adenosine nucleotides in the de novo
biosynthetic pathway [17].
Xanthine-guanine phosphoribosyltransferase is also in-
volved in the xanthine and xanthosine salvage pathway,
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then channeled to the purine nucleotide de novo biosyn-
thesis pathway, and also catalyzes the transformation of
guanine to GMP in the guanine and guanosine salvage
pathway. GMP is, in turn, channeled to the guanosine nu-
cleotide de novo biosynthesis pathway [17]. Additionally,
upregulation was observed for guaC, encoding the GMP
reductase, which catalyzes the conversion of GMP to IMP
by a reductive deamination, and the nrdA gene, encoding
the α-subunit dimer of the ribonucleoside diphosphate re-
ductase 1 enzyme, which catalyzes the conversion of nu-
cleotides to deoxynucleotides, an essential step during
DNA synthesis, including its role in the chromosome rep-
lication and repair processes [17]. Data mining of the
microarray expression comparison between the EXP/
STA1 phases showed no significant expression differences
based on the FDR value ≤ 0.05 for other genes involved in
salvage pathway of pyrimidine ribonucleotides (pyrH, ndk,
pyrG, cmk) or for the pyrimidine de novo biosynthesis
pathway (pyrC, pyrD, pyrE, pyrF, ndk or pyrG) (Additional
file 1). Interestingly, nrdA was found to be upregulated in
the late STA phase, but no other genes involved in the
purine and pyrimidine pathways discussed above were
found to be significantly upregulated in the STA1/STA2
comparison.
All genes encoding enzymes related to the so-called
nucleotide salvage pathways are involved in transforma-
tions of purine nucleotides derived from exogenous
sources, whereas in the de novo pathways, they are syn-
thesized from simpler precursors [67]. Our transcrip-
tomic data, showed the upregulation of few genes
encoding enzymes catalyzing reactions both in the de
novo and salvage pathways involved in the synthesis
of the purines IMP, XMP, GMP and the pyrimidine nu-
cleotide UMP. Upregulation of the above described
genes ensures the availability of rNTPs and dNTPs for
RNA and DNA synthesis, respectively, from both purine
(IMP, XMP, GMP) and pyrimidine (UMP) essential nu-
cleotides during the growth stage of strain PB12.SA22
(Figure 3).
Modification of the cellular membrane during the STA
phase
In the STA1/STA2 comparison, important differences
were observed in the upregulation of several genes pos-
sibly involved in inner and OM structure modification
and the response to diverse environmental processes
with respect to the EXP/STA1 comparison. These in-
clude the arnBC genes encoding an undecaprenyl trans-
ferase involved in the modification of lipid A phosphates
with 4-amino-4-deoxy-L-arabinose (L-Ara4N), which
modifies the lipid composition of the outer face of the
periplasmic membrane [68]; yciE, encoding YciE, a con-
served protein of unknown function, which has beenobserved to be induced under osmotic stress imposed by
NaCl in both aerobic and anaerobic conditions [69];
ygdI, encoding an IM putative lipoprotein [17]; slp,
encoding a STA phase lipoprotein (Slp) that has been
proposed to take part in acid resistance because its ex-
pression was observed when cells were grown in pH 5.5
to 4.5 under conditions known to induce glutamate
dependent acid resistance compared to pH 7.4, and also
associated with YhiF to protect the cell against toxic me-
tabolites [54]. Expression of slp was previously observed
to increase 3-5-fold in the STA carbon starvation and
was found to form homo-oligomer complexes tethered
to the OM [70]. Other genes found to be upregulated
were ydhI (or yhhE), a putative ATPase transporter in-
volved in high cell dependent acid resistance [71]; and
the ompC gene, encoding OmpC. Although the possible
role of OmpC in glucose transport during EXP growth
was discussed above, expression of ompC and OmpC
protein level have been demonstrated to also be influ-
enced by a wide variety of environmental conditions in-
cluding pH, osmolarity, temperature, concentration of
certain toxins, and growth phase [72]. OmpC and OmpF
are reported as the major constituents of the OM in
E. coli, accounting for approximately 2% of the total pro-
tein content of the cell [73]. The role of the OMPs in
the modification of the OM has been previously re-
ported, indicating that the OmpC/OmpT:OmpA ratio
increased in total membrane protein analysis of an
evolved E. coli resistance to increasing isobutanol con-
centrations correlating with upregulation of these genes,
resulting in changes in the OM structure, accomplished
with modification in membrane composition and pep-
tidoglycan structure [74]. Interestingly, in support of our
proposition regarding the possible role of those genes
discussed in this section, particularly during the STA
phase, cell resistance to lysis during the total RNA ex-
traction procedure showed that PB12.SA22 modified its
cellular surface properties because the protocol origin-
ally developed for successful total RNA extraction in the
mid EXP phase (5 h) was modified for the extraction in
the STA phases, thereby enhancing the cellular lysis step
to yield a high amount of total RNA suitable for micro-
array analysis.
Sigma factor regulatory networks controlling the
expression profiles in the EXP and STA phases
We constructed each regulatory network of the sigma
factors controlling upregulated genes observed in EXP/
STA1, EXP/STA2 and STA1/STA2 comparisons. The
sigma regulatory interactions were retrieved from the
comparisons between the information stored in the Eco-
cyc and Regulon DB databases [17,45]. The comparisons
show that the sigma70 (RpoD) was the main sigma factor
targeting promoters for genes encoding amino acid
Cortés-Tolalpa et al. Microbial Cell Factories 2014, 13:28 Page 15 of 20
http://www.microbialcellfactories.com/content/13/1/28metabolism, ATP biosynthetic/catabolic process, trans-
port, electron carrier activity, nucleotide/nucleoside me-
tabolism, cell envelope and stress response (Figure 4).
However, although RpoD is the primary sigma factor
during EXP growth, targeting a wide range of promoters
that are essential for normal growth [75] as is shown in
Figure 4, transcription of several upregulated genes were
possibly controlled by sigma70 and at least one or two
more sigma factors. However, the transcription of other
sets of genes are possibly controlled only by alternative
sigma factors, and interestingly, 17%, 16% and 18% of
significantly upregulated genes during the EXP/STA1,
EXP/STA2 and STA1/STA2 comparisons, respectively,
are controlled by unspecified sigma factors.
Alternative sigma factors possibly controlling tran-
scription of several genes simultaneously to sigma70 dur-
ing EXP/STA1 comparison are sigmaS, sigma32 and
sigma19. Interestingly, the fecA, fecB and fecE genes (en-
coding the ferric citrate OMP, the periplasmic binding
protein and the ATP binding subunit of the dicitrate
ABC transporter, respectively), are located in an operon
with a promoter targeted by sigma19 controlling the ex-
pression of the fecABCD operon genes, whereas the ex-
pression of the contiguous gene in the operon, fecE, is
controlled by sigma70 and sigma19, thus suggesting, as
discussed above, an important role for iron during EXP
growth of strain PB12.SA22. During EXP/STA2 com-
parison, sigmaS and sigma70 were found to be control-
ling the expression of six genes involved in transport
(membrane subunit of the glycine betaine/proline ABC
transporter encoded in the operon proVWX), acid stress
response (hdeAB operon) and DNA binding transcrip-
tional activators (yhiE, yhiW genes), respectively [17].
Data retrieved from the EcoCyc and Regulon DB data-
bases suggested that during the STA phase (the STA1/
STA2 comparison), sigma70 was most likely associated
with the transcription of 35 upregulated genes; however,
in this comparison, it was proposed that the sigmaFigure 4 Proposed transcriptional regulatory network of the sigma fa
comparisons. U, unspecified sigma factor.factors 54, S, 32 and 24 possibly simultaneously participated
with sigma70 RpoD in the co-transcription of 12 genes, in-
cluding those involved in acid stress response (gadBC,
hdeAB and yhiD), nitrite/nitrate transport (yciE), osmotic
stress response (yciE, katE) and DNA binding transcrip-
tional activators (yhiE, yhiW genes) [17] (Figure 4).
Sigma70 accounts for 60-95% of the total pool of cellular
sigma factors during normal EXP growth [17]. Changes to
typical growth conditions, such as heat shock, acid stress
or growth into the STA even in rich broth, lead to the re-
placement of RpoD with other sigma factors such as RpoS,
which is considered to be the master regulator of the gen-
eral stress response in E. coli. RpoS is practically absent in
rapidly growing cells but is strongly induced during entry
into the STA phase and/or many other stress conditions
and is essential for the expression of multiple stress resis-
tances [76]. When wild-type E. coli is grown in glucose-
limiting conditions and, interestingly, in PTS− strains such
as PB12.SA22 parental strain PB12, transcription of sev-
eral central metabolism and especially glycolytic genes
turn on under the control of RpoS, which has been pro-
posed as a second vegetative sigma factor with major im-
pact not only on stress tolerance but on the entire cell
physiology under non-optimal growth conditions [77,78].
However, the comparison of our transcriptomic data
showed that the significantly upregulated genes across
EXP/STA1, EXP/STA2 and STA1/STA2 that are con-
trolled by RpoD average 71%, and interestingly, in the
comparison between EXP/STA2 and STA1/STA2, the
sigmaS factor was involved in the simultaneous upregula-
tion of 22% of those genes controlled by sigma70.
Data mining of differentially expressed genes during
all performed comparisons showed that all genes encod-
ing sigma factors were not significantly up- or downreg-
ulated based on the FDR value ≤ 0.05 (Additional file 1).
This result suggests a relevant role for those positive or
dual transcriptional factors targeting transcription initi-
ation sites of upregulated genes.ctors in E. coli PB12.SA22 in EXP/STA1, EXP/STA2 and STA1/STA2
Cortés-Tolalpa et al. Microbial Cell Factories 2014, 13:28 Page 16 of 20
http://www.microbialcellfactories.com/content/13/1/28Concluding remarks
During batch cultures for SA production using complex
fermentation broth (including 25 g/L of glucose and
15 g/L of YE), strain PB12.SA22 ceased EXP growth
even in the presence of a high amount of residual glu-
cose, indicating that growth was not associated with glu-
cose consumption, depending to some extent of the
availability of nutrients supplied by YE. This hypothesis
was supported by the observation that EXP growth ces-
sation is associated with the total consumption of avail-
able tryptophan in the supernatant, entering a STA-like
phase where a brief increment in biomass was observed.
During this stage, cells consumed residual glucose in the
supernatant, suggesting that biomass produced during
the EXP phase entered a resting cell-like condition pro-
ducing SA. Because no changes were observed in the
regulation of genes involved in CCM and the SA
pathway between the EXP and STA phases, it is pos-
sible to propose that this strain transports and catab-
olizes extracellular glucose mainly for SA production
in the STA phase until 26 h of cultivation, where
glucose was completely consumed. Those metabolic
capabilities regarding glucose catabolism and synthesis
of precursors PEP and E4P for SA production could
be a consequence of the permanent scavenging condi-
tion proposed previously for parental strain PB12, as
a consequence of the inactivation of the PTS operon
and diverse genetic changes developed during an evo-
lutive adaptation process from which the PB12 strain
was obtained [18,79].
GTA of E. coli strain PB12.SA22 during SA production
between the mid EXP phase (5 h), the early STA phase
(9 h) and the late STA phase (44 h) showed no signifi-
cant differences in absolute expression in genes encod-
ing enzymes of CCM, glycolysis, the PPP, TCA, the
glyoxilate shunt, acetate metabolism and gluconeogenic
enzymes, such as those in the SA pathway. However, im-
portant differences were observed in the upregulation of
genes encoding proteins involved in sugar, amino acid,
nucleotide/nucleoside and iron and sulfur transport;
metabolic processes, particularly amino acid catabolism
and biosynthesis; nucleotide/nucleoside salvage; acid
stress response; and the modification of the cell mem-
brane in the EXP/STA1, EXP/STA2 and STA1/STA2
comparisons. Figure 3, shows a proposed metabolic
model based on relevant upregulated genes observed
during comparisons in strain PB12.SA22 during SA pro-
duction in batch-fermentor cultures grown in a complex
broth. During the EXP/STA1 comparison, strain PB12.
SA22 has an important transport activity through OMPs
and IM proteins that possibly transport glucose, sulfur,
iron, amino acids, peptides and nucleotide/nucleosides
whereas amino acid interconversion and catabolism
process were maintained. In the EXP/STA2 comparison,an important reduction in transport activity was ob-
served particularly for some amino acids and possibly
peptides supplied by the YE, while important amino acid
interconversion and catabolism processes, such as nu-
cleotide/nucleoside biosynthesis, were maintained. In
both comparisons, it is important to highlight the catab-
olism of amino acids such as serine, tryptophan and as-
paragine (EXP/STA1) and serine and tryptophan (EXP/
STA2), which results in PYR or Fum, and particularly
the possible catabolism of glycine through the GCV, sug-
gesting the possibility that PYR and Fum could be chan-
neled to the CCM, whereas the catabolism of cysteine
could result in the availability of C1 units for the biosyn-
thesis of cellular blocks. Finally, during the STA1/STA2
comparison, only the transport of arginine, glutamic
acid, and nitrite/nitrate and the biosynthesis of arginine
from glutamic acid were observed. The availability of ar-
ginine and its possible catabolism could yield succinate,
which could be channeled to the TCA. As was discussed,
glucose is completely consumed at 26 h of cultivation,
but SA accumulation continued until the end of fermen-
tation. The results suggest how strain PB12.SA22 con-
tinues producing SA during the late STA phase. Even if
the catabolism of arginine could fuel carbon into TCA
and, possibly, the gluconeogenic capabilities of this
strain could supply PYR and PEP, the availability of E4P
becomes a limiting resource for DAPH synthesis and the
subsequent accumulation of SA. Another important
group of genes upregulated in the STA1/STA2 com-
parison are possibly involved in the cellular response
to pH stress genes (gadB, gadC, hdeA, hdeB) and
several genes encoding proteins possibly involved in
both outer and IM modifications as a response to en-
vironmental conditions imposed on the cell at the
end of the fermentation.
Finally, the network reconstruction based on different
sigma factors controlling the expression of upregulated
genes of each condition showed that even sigmaS has
been proposed to be the master regulator of the STA,
and sigma70 also plays an important role in controlling
some upregulated genes with no alternative reported
sigma factor or any sharing its regulatory region with a
sigmaS promoter or an alternative sigma factor. This
sharing is an important property of regulatory networks,
which gives them plasticity to adapt to different environ-
mental conditions.
Methods
Bacterial strain and growth conditions
The SA-producing strain PB12.SA22 (PTS− ΔaroK ΔaroL
pTOPOaroBaroE, pJLBaroGfbrtktA) [10] was shake-flask
cultured in 125 mL baffled flasks containing 10 mL of Luria-
Bertani broth supplemented with 30 μg/mL of kanamycin,
15 μg/mL of gentamycin, 20 μg/mL of chloramphenicol,
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overnight in a shaker (New Brunswick Scientific, Edison,
USA) at 37°C, 300 rpm. An aliquot of 150 μL of this cul-
ture was used to inoculate a 250 mL baffled flask with
50 mL of fermentation medium containing 25 g/L of glu-
cose and 15 g/L of YE [8,10]. Biomass concentration was
determined, and calculations were performed to adjust
inoculum size at OD600 nm = 0.35 and to inoculate batch
cultures (by triplicate) in an Applikon autoclavable glass
Bio Reactor one L fermentor with a 500 mL working vol-
ume of fermentation medium supplemented with required
antibiotics. Fermentor vessels were connected to an
Applikon ADI 1010 BioController and ADI 1025 control-
lers to monitor temperature, pH, impeller speed and DO.
Batch fermentations were run for 50 h at 37°C, pH 7.0
(maintained by addition of 3.0% of NH4OH). Impeller
speed of no less than 500 rpm was used to maintain DO
levels at 20% air saturation [80]. Gene-carrying plasmids
were induced by adding 0.1 mM of isopropyl β-D-1-
thiogalactopyranoside.Analytical procedures
Biomass concentrations were monitored each hour dur-
ing the first eight h of cultivation. After this point, con-
centrations were monitored every six h until the end of
the fermentation (50 h). Triplicated samples (1.5 mL)
were withdrawn from each reactor and OD600 nm was
determined spectrophotometrically (Beckman DUR-70
Spectrophotometer). Supernatant samples for the deter-
mination of SA, DHP, DHS, and GA were prepared by
centrifuging one mL of fermented broth at 12,000 rpm
for 1 min. To remove any residual cell in the super-
natant, the centrifuged samples were filtered through
0.45 μM nylon membranes. SA, DHS, and GA concentra-
tions were determined by HPLC as described previously
[10], whereas DAHP concentrations were determined by
the thiobarbituric acid assay [81]. Because this method
does not distinguish between DAHP and DAH, in this
work, DAHP levels corresponded to the sum of both
compounds [82]. Glucose concentration was assessed
by a biochemical analyzer (YSI 2700 Select). Aromatic
amino acids phenylalanine, tyrosine and tryptophan,
present in culture supernatants, were quantified using a
Phenomenex Synergy Hydro RP18 column (150 by
4.6 mm; 4 μm) attached to an Agilent 1100 HPLC sys-
tem (Agilent Technologies). Running conditions were as
follows: mobile phase, 0.2% of trifluoroacetic acid 40%
of methanol; flow, 0.5 mL/min. Detection was per-
formed by photodiode array at 280nm [82].
The μ and the qs were calculated during the EXP
growth phase. qs was calculated as the differential
change in S, with time (t) normalized to the biomass
concentration ( qs ¼ μYx=s ). A predetermined correlationfactor (1 OD600 nm corresponded to 0.37 g/L of DW)
was used to transform OD600 nm values into cell concen-
trations for qs and μ calculation.
TACY determinations were based on the combined
molar yields of DAHP, DHS, SA, and GA [10]. Results
were reported as the average of triplicated samples with
their associated standard deviation.
RNA extraction procedures
One aliquot of 5 mL from each of three fermentor cul-
tures performed were collected at the middle of the EXP
growth phase (5 h, DO600 nm = 7.00), the early STA state
(9 h, DO600 nm = 13.00) and the late STA state (44 h,
DO600 nm =15.2) (resulting in triplicate samples for each
time), and transferred to a 15-mL Falcon tube contain-
ing 500 μL of RNA later solution (Ambion). Total RNA
extraction was performed using a modification of the
previously reported hot phenol-based procedure. Previ-
ous methodology was used successfully for total RNA
extraction from cultures of E. coli JM101, and its PTS−-
derivative PB11 and PB12 strains, grown in batch-
fermentor cultures in minimal M9 medium and collected
at DO600 nm = 1.0 [18]; however, direct application of
this methodology to biomass collected from cultures of
strain PB12.SA22 for SA production in a complex
medium resulted in poor total RNA yield, particularly in
samples collected during STA. To obtain total RNA of
high quality (non-degraded and with high absorbance
DO260/280 and DO230/260 ratios) and concentration re-
quired to perform successful GTA, the original RNA ex-
traction procedure was modified and optimized. The
integrity of extracted total RNA was evaluated by agar-
ose gel electrophoresis, and quality was evaluated by
determination of concentration and the DO260/280 and
DO260/230 ratios in a Nanodrop-2000c spectrophotom-
eter (Thermo Scientific). Samples were adjusted to a
final concentration of total RNA = 1 μg/μL. Aliquots
of 20 μL of total RNA were shipped to the Precision
Biomarker company for microarray experiments (www.
precisionbiomarker.com).
Microarray design, experiments and data analysis
Total RNA extracted from each samples withdrawn at 5,
9 and 44 h from triplicated fermentor cultures, were en-
tirely processed by Precision Biomarker. Sample prepar-
ation and processing included cDNA synthesis, cDNA
fragmentation, and the preparation of the hybridization
mixture, hybridization with the Affymetrix GeneChip®
E. coli Genome 2.0 (Affymetrix), washing, staining, and
scanning of the microarrays, which were all performed
according to the manufacturers’ procedures. Raw data
acquisition and gene expression data analysis were per-
formed by Precision Biomarker using background cor-
rection, normalization and summarization. The resulting
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analyzed in our laboratory by retrieving expression data
from the array of E. coli MG1655, including in the Affy-
metrix GeneChip® E. coli Genome 2.0. Average data of
triplicates from each growth phase sampled were used
to calculate the relative expression value between EXP
relative to STA1 (EXP/STA1 (2^(EXP-STA1)), STA1 relative to
STA2 (STA1/STA2 (2^(STA1-STA2)) and EXP relative to STA2
(2^(EXP-STA2)). The resulting databases were formatted using
a Perl language program from http://www.gla.ac.uk/schools/
computing/?CFID=21255484&CFTOKEN=17693561 for
analysis by the rank product method to identify differentially
expressed (upregulated or downregulated) genes [15,16].
Additional file
Additional file 1: Differentially upregulated and downregulated
genes during EXP/STA1, EXP/STA2 and STA1/STA2 comparisons
based on the application of the RP defined by a FDR value ≤ 0.05.
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